BlackRock Investment Management, LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 62 filers reported holding IMMUNE DESIGN CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$304,000
-24.6%
55,251
+3.9%
0.00%
Q3 2016$403,000
+17.8%
53,161
+26.9%
0.00%
Q2 2016$342,000
-33.5%
41,876
+6.0%
0.00%
-100.0%
Q1 2016$514,000
-34.1%
39,511
+1.7%
0.00%0.0%
Q4 2015$780,000
+64.9%
38,857
+0.2%
0.00%0.0%
Q3 2015$473,000
-50.1%
38,788
-15.5%
0.00%0.0%
Q2 2015$948,000
+148.8%
45,901
+154.5%
0.00%
Q1 2015$381,000
-29.6%
18,039
+2.6%
0.00%
-100.0%
Q4 2014$541,000
+115.5%
17,579
+23.8%
0.00%
Q3 2014$251,00014,2050.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2015
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders